Argenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren's disease on Thursday. The stock plummeted in response.
Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's Investor's Business Daily.
Hence then, the article about former highflier argenx plummets on a surprise setback in sjogren s was published today ( ) and is available on IBD ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's )
Also on site :
- Witney Carson Claps Back at ‘DWTS’ Judge Carrie Ann Inaba, Joining Uproar Over Comments on Guillermo Rodriguez: ‘I Said What I Said’
- ‘The Debut’: Jesse Eisenberg Praises Oscar Frontrunner Julianne Moore’s ‘Perfect Performance’ at NYFF
- James Gunn Responds to ‘Clayface’ Criticism: ‘The Public Voting on What IP They Want to See’ Isn’t ‘the Only Way to Make a Movie’